Orthopediatrics outlines $270M-$273M 2026 revenue outlook and targets $25M adjusted EBITDA
Summary
Orthopediatrics outlined a 2026 revenue outlook of $270 million to $273 million and said it is targeting $25 million in adjusted EBITDA and free cash flow breakeven or better, according to a Seeking Alpha breaking news report. The summary is based on the headline only, as the article's body was not available.
Timeline
Seeking Alpha
Source ↗Reports that Orthopediatrics outlined a $270M-$273M 2026 revenue outlook while targeting $25M in adjusted EBITDA and free cash flow breakeven or better.
Comments
No comments yet.
to like and comment.